Amgen
Amgen Inc.
1 Amgen Center Drive
Thousand Oaks,
CA 91320-1799
Phone: (805) 447-1000Website: https://www.amgen.com/Careers: careers.amgen.comPatient Assistance Program: wwwext.amgen.com/responsibility...
Latest news
- Amjevita™ (adalimumab-atto), First Biosimilar To Humira®, Now Available In The United States
31 January 2023 - FDA Approves Riabni (rituximab-arrx), a Biosimilar to Rituxan (rituximab), for Adults with Moderate to Severe Rheumatoid Arthritis
7 June 2022 - FDA Approves Repatha (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
24 September 2021 - FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
28 May 2021 - Amgen Provides Updated Information on Lumakras (sotorasib) Dose Comparison Study
28 April 2021 - FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
16 February 2021 - Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
28 January 2021 - FDA Approves Riabni (rituximab-arrx), a Biosimilar to Rituxan
17 December 2020 - Amgen's Sotorasib Granted Breakthrough Therapy Designation For Advanced Or Metastatic Non-Small Cell Lung Cancer Patients With KRAS G12C Mutation
8 December 2020 - Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
5 October 2020
Drugs Associated with Amgen Inc.
Amgen Inc. manufactures, markets and/or distributes more than 26 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Aimovig
Generic name: erenumab Drug class: CGRP inhibitors |
539 reviews | 4.9 / 10 |
|
Amjevita
Generic name: adalimumab Drug class: antirheumatics, TNF alfa inhibitors |
3 reviews | 6.3 / 10 |
|
Aranesp
Generic name: darbepoetin alfa Drug class: recombinant human erythropoietins |
4 reviews | 9.0 / 10 |
|
Avsola
Generic name: infliximab Drug class: TNF alfa inhibitors |
3 reviews | 2.0 / 10 |
|
Blincyto
Generic name: blinatumomab Drug class: CD19 monoclonal antibodies |
||
|
Corlanor
Generic name: ivabradine Drug class: miscellaneous cardiovascular agents |
6 reviews | 8.2 / 10 |
|
Enbrel
Generic name: etanercept Drug class: antirheumatics, TNF alfa inhibitors |
275 reviews | 7.8 / 10 |
|
Epogen
Generic name: epoetin alfa Drug class: recombinant human erythropoietins |
2 reviews | 8.5 / 10 |
|
Evenity
Generic name: romosozumab Drug class: miscellaneous bone resorption inhibitors |
20 reviews | 4.3 / 10 |
|
Imlygic
Generic name: talimogene laherparepvec Drug class: miscellaneous antineoplastics |
||
|
Kanjinti
Generic name: trastuzumab |
||
|
Kyprolis
Generic name: carfilzomib Drug class: proteasome inhibitors |
3 reviews | 4.3 / 10 |
|
Lumakras
Generic name: sotorasib Drug class: miscellaneous antineoplastics |
||
|
Mvasi
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
||
|
Neulasta
Generic name: pegfilgrastim Drug class: colony stimulating factors |
62 reviews | 5.4 / 10 |
|
Neupogen
Generic name: filgrastim Drug class: colony stimulating factors |
3 reviews | 10 / 10 |
|
Nplate
Generic name: romiplostim Drug class: platelet-stimulating agents |
5 reviews | 7.0 / 10 |
|
Otezla
Generic name: apremilast Drug class: antirheumatics |
388 reviews | 5.0 / 10 |
|
Parsabiv
Generic name: etelcalcetide Drug class: calcimimetics |
||
|
Prolia
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
321 reviews | 2.7 / 10 |
|
Repatha
Generic name: evolocumab Drug class: PCSK9 inhibitors |
454 reviews | 4.4 / 10 |
|
Riabni
Generic name: rituximab Drug class: CD20 monoclonal antibodies |
||
|
Sensipar
Generic name: cinacalcet Drug class: calcimimetics |
9 reviews | 5.7 / 10 |
|
Tezspire
Generic name: tezepelumab Drug class: selective immunosuppressants |
2 reviews | 5.5 / 10 |
|
Vectibix
Generic name: panitumumab Drug class: EGFR inhibitors |
3 reviews | 6.3 / 10 |
|
Xgeva
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
7 reviews | 6.1 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||